Amgen Inc. (NASDAQ:AMGN) is investing $650 million to expand its biologics facility in Puerto Rico, creating 750 new jobs. The move follows previous investments in Ohio and North Carolina to support its growing product pipeline. Q2 2025 results show strong revenue growth and positive analyst outlook despite recent market trends.

The expansion of the biologics facility is part of Amgen Inc.’s (NASDAQ:AMGN) strategy to enhance production and operational resilience in the U.S. The $650 million investment will create new jobs and shield the company from tariffs on imported pharmaceuticals. The firm’s financial results in Q2 2025 reflect revenue growth and positive analyst sentiment.

Read more at Yahoo Finance: Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs